Skip to main content

MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

04 Nov 2026 Evaluate
A minor change in the total revenue was seen in the September 2026 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Total Profit for the quarter ended September 2026 of Rs. 2.57 millions grew from Rs.-4.91 millions Operating profit Margin for the quarter ended September 2026 improved to 2.57% as compared to -4.91% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 0.00 0.00 0.00 4.43 15.43 -71.29 25.58 8.38 205.25
Other Income 2.83 -1.05 -369.52 2.83 -1.05 -369.52 0.00 0.00 0.00
PBIDT 2.57 -4.91 -152.34 4.78 8.54 -44.03 9.57 -2.93 -426.62
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.57 -4.91 -152.34 4.78 8.54 -44.03 9.57 -2.93 -426.62
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 2.57 -4.91 -152.34 4.78 8.54 -44.03 9.57 -2.93 -426.62
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.97 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 2.57 -4.91 -152.34 4.78 8.54 -44.03 8.60 -2.93 -393.52
Equity 1053.04 902.60 16.67 1053.04 902.60 16.67 902.60 652.60 38.31
PBIDTM(%) 0.00 0.00 0.00 107.90 55.35 94.95 37.41 -34.96 -207.00
Peers
Company Name CMP
Redington 349.60
Adani Enterprises 2682.00
Amrapali Industries 32.78
Maxgrow India 174.80
Rashi Peripheral 689.15
View more..